BLOG

Bioanalysis at Quotient Sciences - Q&A with Stuart McDougall

Read here

About us

Translational Pharmaceutics

Quotient Sciences first brought meaningful innovation to the pharmaceutical industry in 2008 with Translational Pharmaceutics® - a unique delivery platform which shortens development times by more than 12 months.

By integrating drug product and clinical testing activities, Translational Pharmaceutics accelerates molecules through development. This saves time and money in reaching key milestones as quickly and efficiently as possible, ensuring better decision making and more streamlined outsourcing.

Rapid-Make-Test-Cycles-Infographic
  • Accelerating molecules from First-in-Human to Proof-of-Concept
  • Selecting and optimizing clinical formulations
  • Accelerating products through to commercial manufacture

Translational Pharmaceutics has now been used by pharma and biotech companies on over 400 drug programs. The financial benefits and time savings were quantified in a publication by the Tufts Center for the Study of Drug Development.

Translational Pharmaceutics

  • A faster approach to drug development and accelerated time to market
  • Timeline acceleration of >12 months
  • Significant reduction in R&D spend
  • Better decision making
  • Greater likelihood of success
  • Simplified supply chain
Get in touch
Humanity can’t afford to wait, so neither can we.
Let’s talk.
We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.